|
gptkbp:instanceOf
|
gptkb:vaccine
|
|
gptkbp:approvedBy
|
gptkb:World_Health_Organization
gptkb:European_Medicines_Agency
gptkb:U.S._Food_and_Drug_Administration
2020
|
|
gptkbp:boosterRecommended
|
Yes
|
|
gptkbp:boosters
|
Yes
|
|
gptkbp:category
|
gptkb:COVID-19
Immunization
|
|
gptkbp:clinicalTrialPhase
|
Phase 3
|
|
gptkbp:contains
|
gptkb:gene
Inactivated virus
Protein subunit
Viral vector
|
|
gptkbp:contraindication
|
Severe allergic reaction to vaccine component
|
|
gptkbp:developedBy
|
gptkb:Moderna
gptkb:AstraZeneca
gptkb:Johnson_&_Johnson
gptkb:Covaxin
gptkb:Sputnik_V
gptkb:Pfizer-BioNTech
gptkb:Sinopharm
gptkb:Sinovac
|
|
gptkbp:effect
|
Varies by vaccine
|
|
gptkbp:emergencyServices
|
Yes
|
|
gptkbp:form
|
gptkb:Single_dose_(Johnson_&_Johnson)
Two doses
|
|
gptkbp:globalPresence
|
Over 200 countries
|
|
gptkbp:monitors
|
gptkb:Centers_for_Disease_Control_and_Prevention
gptkb:World_Health_Organization
gptkb:European_Medicines_Agency
|
|
gptkbp:publicHealthConcern
|
Reduced COVID-19 deaths
Reduced COVID-19 hospitalizations
Reduced transmission
|
|
gptkbp:recommendation
|
Adults
Children (age varies by country)
|
|
gptkbp:routeOfAdministration
|
Intramuscular injection
|
|
gptkbp:sideEffect
|
Fever
Fatigue
Headache
Chills
Muscle pain
Injection site pain
|
|
gptkbp:storage
|
gptkb:2-8°C_(AstraZeneca)
-20°C (Moderna)
-70°C (Pfizer-BioNTech)
|
|
gptkbp:target
|
gptkb:COVID-19
|
|
gptkbp:usedFor
|
Prevention of COVID-19
|
|
gptkbp:bfsParent
|
gptkb:Immunization_Clinic
|
|
gptkbp:bfsLayer
|
7
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
COVID-19 Vaccine
|